Literature DB >> 93204

Serum-sickness-like syndrome with membranous glomerulopathy in patient on captopril.

S J Hoorntje, J J Weening, C G Kallenberg, E J Prins, A J Donker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 93204     DOI: 10.1016/s0140-6736(79)92303-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

Review 2.  ACE inhibitors and proteinuria.

Authors:  R T Gansevoort; D de Zeeuw; P E de Jong
Journal:  Pharm World Sci       Date:  1996-12

3.  Arthralgia associated with captopril.

Authors:  S D Malnick; A Schattner
Journal:  BMJ       Date:  1989-08-05

4.  Inhibitors of angiotensin I converting enzyme for treating hypertension.

Authors: 
Journal:  Br Med J       Date:  1980-09-06

5.  How adverse drug reactions can play a role in innovative drug research.

Authors:  F Rikken; R Vos
Journal:  Pharm World Sci       Date:  1995-11-24

Review 6.  Human serum sickness.

Authors:  S M Naguwa; B L Nelson
Journal:  Clin Rev Allergy       Date:  1985-02

7.  Long-term effect of captopril on kidney function in various forms of hypertension.

Authors:  W Vetter; M Wehling; E C Foerster; U Kuhlmann; H J Boerlin; P Greminger; H Vetter
Journal:  Klin Wochenschr       Date:  1984-08-01

Review 8.  Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.

Authors:  I A Jaffe
Journal:  Springer Semin Immunopathol       Date:  1981

9.  Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.

Authors:  K O Stumpe; A Overlack; R Kolloch; S Schreyer
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 10.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.